Wellgistics Health (fka Danam Health), a pharmaceutical wholesaler focused on independent pharmacies, raised $4 million by offering 0.9 million shares at $4.50, the low end of the range of $4.50 to $5.50. The IPO float is just 1.7% of basic shares outstanding.
Because the company raised less than $5 million, Wellgistics Health will be excluded from Renaissance Capital's 2025 IPO stats.
Wellgistics Health plans to list on the Nasdaq under the symbol WGRX. Craft Capital Management and D. Boral Capital acted as joint bookrunners on the deal.
